GLP – (T) 40MG Vial

Description

Tirzepatide is a groundbreaking synthetic peptide designed to mimic the action of two key incretin hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Known as a dual agonist, Tirzepatide has become a significant focus in research for its potential to regulate glucose metabolism, reduce body weight, and improve overall metabolic health.

Its unique ability to target both GLP-1 and GIP receptors makes it a novel and versatile tool for studying metabolic pathways.

Key Areas of Research Interest:

• Weight Management: Explored for its role in appetite suppression and enhanced fat metabolism.
• Glucose Control: Investigated for its potential to improve insulin sensitivity and glycemic regulation.
• Metabolic Health: Studied for its impact on conditions like obesity, type 2 diabetes, and metabolic syndrome.
• Cardiovascular Benefits: Examined for its potential to improve lipid profiles and cardiovascular markers.

Tirzepatide’s dual-action mechanism represents an innovative approach to studying hormonal regulation and metabolic health, positioning it as a promising compound for advanced research.

Specifications:

• Purity: >98% (lab-verified)
• Format: Lyophilized powder for reconstitution
• Molecular Formula: C225H348N48O68
• CAS Number: 2023788-19-2

Intended Use:
For research purposes only. Not for human consumption, injection, or topical application.

Storage Guidelines:
Store the lyophilized powder in a cool, dry location, away from direct sunlight. Once reconstituted, refrigerate at 2–8°C and use within the recommended timeframe to maintain stability.

Disclaimer:
This product is intended solely for laboratory and scientific research purposes. It is not approved for diagnostic, therapeutic, or human use.